Uvadex

DRUG3 trials

Sponsors

Universitätsklinikum Hamburg-Eppendorf, London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Central Hospital, Nancy, France

Conditions

Acute-graft-versus-host DiseaseDiffuse Cutaneous Systemic SclerosisGraft Vs Host Disease

Phase 2

Extracorporal Photopheresis With UVADEX Plus Standard Steroid Treatment for High Risk Acute Graft-versus-host Disease

Active, not recruitingNCT04291261

Universitätsklinikum Hamburg-EppendorfAcute-graft-versus-host Disease

Start: 2020-05-18End: 2025-06-30Updated: 2025-03-30

Extracorporeal Photopheresis in Early Diffuse Cutaneous Systemic Sclerosis

Not yet recruitingNCT04986605

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sDiffuse Cutaneous Systemic Sclerosis

Start: 2025-07-01End: 2027-07-31Target: 15Updated: 2025-03-13

Steroids Versus ECP and Steroids as First-line Treatment of Grade II Acute GVHD

Not yet recruitingNCT06133192

Central Hospital, Nancy, FranceGraft Vs Host Disease

Start: 2024-01-31End: 2026-01-31Target: 42Updated: 2023-11-15